Sean Toomey, MD
Orthopaedic Surgery · Seattle, WANPI 1003876343
Payments from drug & device makers
Across 1,050 payments — averaging $1217.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.3M
- Davol Inc.$514
- BD$164
- Johnson & Johnson$121
- Medacta USA, Inc.$59
- Tersera Therapeutics LLC$32
- plus $18 from 1 others
What the payments were for
- Consulting fees$1,017,20286%
- Travel & lodging$143,01312%
- Food & beverage$25,4312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1,041 | $1,277,499 |
| Davol Inc. | 3 | $514 |
| BD | 1 | $164 |
| Johnson & Johnson(2 entities) | 2 | $121 |
| Medacta USA, Inc. | 1 | $59 |
| Tersera Therapeutics LLC | 1 | $32 |
| Radius Health, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,108,637
- TRIATHLON$47,451
- INSIGNIA$38,751
- EXETER$35,546
- ACCOLADE$26,274
- TRIDENT$21,692
- RESTORATION$20,750
- Verasense$3,960
- BIOLOX$3,945
- MOTIONSENSE DIGITAL GONIOMETER$3,000
- NONE$2,500
- GMRS$2,250
- TRITANIUM$500
- ARISTA$247
- RIO$216
- ARISTA AH FLEXITIP$164
- NASOPORE$156
- Viaflow$142
- INBONE$142
- AUGMENT INJECTABLE$142
How this compares
$1,278,409 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 80 | $120 |
| Cephalexin | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Seattle
- James PritchettSeattle$6.4M
- Jeffrey RohSeattle$4.7M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Burt YaszaySeattle$1.5M
- Robert HartSeattle$942K
- Daniel SchwartzSeattle$508K
- Michael BrageSeattle$507K
- Grant GarciaSeattle$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.